MSPEECH (multiple sclerosis monitoring through speech interaction in clinic and at home): a Living Lab study protocol for co-created, speech-based digital biomarkers in multiple sclerosis
Jul 2026· Frontiers in Digital Health· Vol 8· 0 citations· 36 references
Medicine
TL;DR
MSPEECH is a single-center, prospective, non-interventional Living Lab study at the MS Center Dresden conducted with ki:elements GmbH to co-create and iteratively refine the Mili smartphone/tablet speech assessment app.
Abstract
Multiple sclerosis (MS) has heterogeneous trajectories and fluctuating symptoms that are often not captured by intermittent clinic assessments. Digital health tools can provide frequent, low-burden measurements, but clinical translation requires sustained engagement, interpretability, robust governance, and workflow integration. MSPEECH is a single-center, prospective, non-interventional Living Lab study at the MS Center Dresden conducted with ki:elements GmbH to co-create and iteratively refine the Mili smartphone/tablet speech assessment app. The protocol comprises three demonstrator cycles with structured co-design (people with MS and clinicians), implementation within predefined boundaries while keeping core tasks/schedules/security stable, and a 12-week home-based evaluation per version. The battery includes multiple speech tasks (e.g., fluency, reading, “Pa–Ta–Ka,” sustained phonation) and a dual-task module combining touchscreen fine-motor tracking with concurrent speech. A dedicated Ethical, Legal and Social Issues (ELSI) board provides continuous oversight. Primary outcomes are usability and acceptability (MAUQ plus qualitative feedback); secondary outcomes include feasibility/engagement, privacy perceptions, report interpretability, clinician workflow fit, and exploratory associations with clinical reference indicators.
Background Major depressive disorder is a severe, recurrent and disabling condition. Although diagnosis and clinical monitoring are based on medical interviews and validated rating scales, voice and speech analysis may provide complementary digital biomarkers reflecting depressive severity and clinical evolution. Howev...
M. Zabalza-Zudaire, O. Sayar-Beristain, P. Fructos et al.· PLoS ONE· 0 citations
Background: Parkinson’s Disease (PD) manifests differently in every person, causing symptoms ranging from slowed speech and memory issues to tremors and hampered gait movements; thus, treatment requires a more individualized approach. While direct medical treatments can improve impaired motor functioning, non-medical a...
Mayya Hashmi, K. Ball, Tanya Henderson et al.· International Journal of Int...· 0 citations
Voice and speech encode acoustic, linguistic, and interactional information associated with mental health. Translating these signals into clinically meaningful digital biomarkers depends not only on predictive performance but on how speech is elicited, how the target state is defined, whether findings generalize be...
Ralph Justin Uy, Ibrahim Shaaban, Angel Arnaout· Frontiers in Digital Health· 0 citations
Post-stroke aphasia is a profoundly disruptive neurogenic communication disorder that severely impacts not only the individual’s linguistic capacity but also the entire structural, functional, and emotional fabric of the family unit. Historically, clinical speech and language therapy (SLT) has prioritized impairment-ba...
Aisha Fawzy Abdel Hady· The Egyptian Journal of Otol...· 0 citations
Although evidence-based recommendations for aphasia rehabilitation exist, guideline-based speech and language therapy is still not consistently implemented in routine care. Previous studies have described barriers to therapy participation from the perspective of people with aphasia, but less is known about how these ba...
Susann May, F. Muehlensiepen, Laura Plotho et al.· BMC Health Services Research· 0 citations
Abstract Introduction Parkinson’s disease (PD) is the second most common neurodegenerative disorder, its principal symptom being deterioration of motor function. Current treatment options are limited to symptom management but there is evidence that physical activity can provide motor benefits. More recently there is ev...
Rebecca Hamilton, Eirwen Malin, N. Kirby et al.· BMJ Open· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.